ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced completion of enrollment in its Phase 2 clinical trial evaluating ANKTIVA® (nogapendekin alfa inbakicept-pmln) ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

By Dr. Priyom Bose, Ph.D. Inviting adults to colorectal cancer screening at age 60 shifts diagnoses to earlier stages without ...

The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...

Turn Therapeutics (NASDAQ:TTRX) executives outlined the company’s focus on inflammatory skin disease and provided updates on its lead topical candidate, GX-03, during a presentation at an ...

Ooops... Something went wrong while loading this page.

This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...

"Disappointing" trial results, but some researchers remain hopeful ...

If the future of work were determined by headline volume, the office would already be overflowing. Inside most companies, the ...

Less artery-clogging plaque in women's arteries did not appear to protect them from heart disease compared to men, according ...

Theresa S Betancourt and colleagues argue that implementation and systems strengthening are urgently needed to integrate mental health and psychosocial support interventions across health, education, ...

The prevalence of waterpipe smoking (WPS) is increasingly recognised as a growing global public health concern. Available studies show that WPS exposes users to toxicants at levels similar to or ...